Background Whilst the pharmacological profiles and mechanisms of antidepressants are
varied, there are common reasons why they might help people to stop smoking tobacco …

Monoamine oxidase inhibitors were among the first antidepressants to be discovered and
have long been used as such. It now seems that many of these agents might have …

This book uses a clinically oriented approach for working with patients and clients with
substance-use disorders. The material represents a blending together of my three major …

Introduction: Monoamine oxidase (MAO) inhibitors, after the initial 'golden age', are currently
used as third-line antidepressants (selective MAO-A inhibitors) or clinically enrolled as co …

Strategies for assisting smoking cessation include behavioural counselling to enhance
motivation and to support attempts to quit and pharmacological intervention to reduce …

Aims To assess the validity of the French version of the Modified Reasons for Smoking Scale
(MRSS), and to identify which smoking patterns differentiate male and female smokers …

Recent reports document that α‐tetralone (3, 4‐dihydro‐2H‐naphthalen‐1‐one) is an
appropriate scaffold for the design of high‐potency monoamine oxidase (MAO) inhibitors …

Introduction: Monoamine oxidase (MAO) inhibitors, despite the initial pharmacological
interest, are used in clinic for their antidepressant effect and in the management of …

This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-
analysis of the Cochrane Library. Six placebo-controlled trials have shown nortriptyline (75 …

Tobacco dependence remains the leading cause of death and disease in the US and a
major cause of mortality around the world, yet 1 out of 5 American adults smoke and 1.3 …